Why we ask: Nine out of ten patients pay $0 for MyRisk testing through insurance. However, there may be out-of-pocket costs for those without insurance.
Is your insurance government-sponsored (i.e., Medicare, Medicaid, Medicare Advantage)?
Why we ask: Government-sponsored health insurance plans sometimes require additional steps for genetic testing, so knowing this information helps us get you on the best path.
There may be out-of-pocket costs for those without insurance coverage. But we, at Myriad, are committed to providing affordable access to testing and comprehensive support for all appropriate patients and their families. If you have additional questions, visit our Costs & Process page for more information.
Why we ask: Some insurance providers require additional steps for genetic testing, so knowing this information helps us get you on the best path to testing.
In order to take the next step, you’ll need to work with a healthcare provider to order the test and discuss your results.
We’ve partnered with Genome Medical’s nationwide network of clinical and genetic experts to provide care to you through the testing process for a $179 consult fee that may be covered by your insurance. Get started now, all from the comfort of your home.
In order to take the next step, you’ll need to work with a healthcare provider to order the test and discuss your results. We’ve partnered with Genome Medical’s nationwide network of clinical and genetic experts to provide care to you through the testing process for a $42 consult fee, all in the comfort of your home.
Whether you’ve heard about hereditary cancer testing before or want to learn more, we can help. We’re happy to provide in-depth information on how to get tested.
Myriad needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.
What if you could do more to understand your risk of breast cancer? Myriad’s MyRisk® Hereditary Cancer Test can help identify hereditary cancer risks and empower you and your provider to take action for your health today and into the future.
Hereditary cancer testing is a type of genetic test. It looks for genetic changes linked to a higher chance of developing certain cancers, like breast cancer. These genetic changes can be passed down in families. Hereditary cancer testing can give you and your healthcare provider important information to help manage your breast health.
in an OB/GYN setting meet criteria for hereditary cancer testing.1
1. DeFrancesco, et al. 2018
MyRisk can help you and your provider understand your risk of developing 11 different types of cancer, including breast cancer. It can also provide important information for your family members if your test reveals a genetic change associated with hereditary cancer.
A more complete picture of cancer risk with RiskScoreFor most patients, MyRisk test results also include RiskScore, a personalized estimate with five-year and remaining lifetime risk for developing breast cancer.
MyRisk test results are available ~two weeks after your blood or saliva sample is received at our lab. Watch this video to understand how it works, what your results could mean, and what comes next.
Watch video
Connect with us for more information on hereditary cancer testing.
Sign up
Learn more
MyRisk Patient Story
Lisa’s mom’s battle with breast cancer inspired her to get genetic testing and make a life-saving choice. Her story is a testament to courage and resilience.
Because we work with most major insurance companies, 9 out of 10 patients have no cost to them2. However, for those paying out of pocket, we provide cost estimates up front, so you know your costs before you commit. Financial assistance is also available to those who qualify. For further cost questions, visit our Costs & Process page.
2. Based on internal Myriad data, 2023
Unlike recreational genetic tests, MyRisk® is a medical grade test that requires a healthcare provider’s signature to initiate testing. If you don’t have a healthcare provider or would prefer to test from the comfort of your home, consider our Virtual Care services which connect you to a genetic counselor who will help you to submit your test sample.
Every results report is unique to the individual and provides an individualized risk estimate. Moreover, MyRisk produces personalized care plans that providers can use to help patients manage their risk. The plans can recommend a wide range of proactive options from risk reduction strategies to additional screenings.
Hereditary cancer testing can give you and your healthcare provider necessary information to help manage your hereditary risk before the onset of cancer or before a second cancer has a chance to develop. Even if you have been diagnosed and treated in the past, MyRisk can still inform your future cancer risk.
Testing could also be beneficial for discussing risks with your family members.
Tyrer-Cuzick is a calculation used to estimate a person’s chance of developing breast cancer. It looks at your family history of cancer and other personal risk factors. If your chance of developing breast cancer in your lifetime is calculated to be 20% or greater, you may benefit from extra breast cancer screening.
If you take the MyRisk Test, a Tyrer-Cuzick score may be included. If your score is >20%, you'll be given a summary of medical care options to discuss with your healthcare providers.
MyRisk does not diagnose cancer. It is a test to evaluate your hereditary risk of developing 11 types of cancer. Myriad representatives are unable to provide medical advice or help diagnose any symptoms and recommend consulting with your healthcare provider.
Average turnaround time is within 14 days of sample submission.